Abstract

Objectives To evaluate the predictive performance of a newly developed delay alternating with nutation for tailored excitation (DANTE) pulse sequence for detecting lower extremity artery wall morphology and distribution in patients with peripheral artery disease (PAD) with diabetes. Methods Seventy-four PAD patients diagnosed according to 2011 WHO criteria were enrolled, who has diabetic diagnosis by 1999 WHO diabetes criteria. All patients received sequential DANTE, T2WI, DANTE-enhance, and CE-MRA scans. The images consisted of three parts: the iliac artery (segment 1), femoral artery (segment 2), and popliteal artery (segment 3). Regions of interest (ROIs) were drawn on vessels, muscle, and background, and multiple imaging metrics compared between modalities, including image quality score, image noise, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). In the images with a score greater than 2, the lumen area (LA), total vessel area (TVA), and vessel thickness (VT) can be identified using semiautomatic image analysis vessel morphology parameters. Results All 222 arterial segments were successfully analyzed from 71 patients, after exclusion of three subjects with poor image quality (IQ < 2) in segment 3. There were 54 diabetic and 17 nondiabetic patients. Quantitative analysis shows that the CNR difference between diabetic patients and nondiabetic patients was statistically significant for the same segment, while there was no significant difference among the three segments of SNR and CNR. There were a total of 54 diabetics with plaque distribution data, which showed that LA of segments 1 and 2 was higher than that of segment 3. The VWI of segments 1 and 2 was lower than segment 3. Diabetic was associated with vascular WT 3 and WA3, which increased by 0.23 and 0.83 units on average compared without diabetic foot, respectively. Diabetic foot was associated with vascular WT 3, which increased by 0.37 units on average compared without diabetic foot. The incidence of segment 3 plaques was higher than that of segment 1. The incidence of the left and right plaques was different. Conclusions MR imaging using the DANTE and multicontrast sequence could evaluate plaque morphology, and distribution of lower extremities and the occurrence of diabetic foot development are closely related; it may predict occurrence of PAD with diabetic foot.

Highlights

  • 120 million people in China are currently affected by patients with diabetes, which has resulted in an 11.6% incidence in China

  • We evaluated image signal-to-noise ratio (SNR), which measured arterial signal intensity divided by the calculated noise define as a quantitative evaluation

  • Diabetes was associated with vascular vessel thickness (VT) 3 and WA3, which increased by 0.23 and 0.83 units on average compared without diabetic foot, respectively (p = 0:04, p = 0:01) (Table 4)

Read more

Summary

Introduction

120 million people in China are currently affected by patients with diabetes, which has resulted in an 11.6% incidence in China. The incidence of peripheral artery disease (PAD) in diabetic patients is twice as high as in nondiabetic patients [2]. The prevalence rate of PAD in type 2 diabetes patients over 50 years old was 21.2% [3]; PAD of lower extremity arterial lesions is one of the most important pathogenesis of diabetic foot. PAD was present in 47.5% of diabetic foot patients among patients. The rate of PAD diagnosis and treatment of diabetes is low, which is often ignored by the clinic. The rate of missed diagnosis reaches 55.7%, leading to a high incidence of foot ulcer, amputation rate, and mortality of diabetic patients. PAD China’s prevention and cure of diabetic foot patients with diabetes guide (2019 edition) (II) [5, 6] points out that early diagnosis and intervention of the PAD are the key to the prevention of diabetic foot, and its prognosis predictions may have some significance

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call